Clinical trial
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis
NCT00243685 · Pierian Biosciences, Industry · Completed
Key facts
| NCT number | NCT00243685 |
|---|---|
| Title | Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis |
| Official title | Application of the Microculture Kinetic (MiCK) Assay for Apoptosis to Drug Testing Sensitivity of Solid Tumors |
| Lead sponsor | Pierian Biosciences, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma, Soft Tissue |
| Intervention type | Other |
| Interventions | Laboratory Assay, Mick Assay |
| Enrollment | 150 |
| Start date | Sep 1, 2006 |
| Completion | May 1, 2009 |
| First posted | Oct 24, 2005 |
| Last update posted | Jan 26, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: